Skip to main content
logo
enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
8.98
+0.19 (2.10%)
At close: Sep 18, 2026, 4:00 PM EDT
9.15
+0.18 (1.95%)
After-hours: Sep 18, 2026, 4:20 PM EDT

enVVeno Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
8.6610.9211.5811.6615.0211.17
Research & Development
8.729.9812.2513.589.915.73
Operating Expenses
17.3820.923.8325.2424.9316.89
Operating Income
-17.38-20.9-23.83-25.24-24.93-16.89
Interest & Investment Income
0.310.690.390.180.160.02
Other Non Operating Income (Expenses)
-----0.03
EBT Excluding Unusual Items
-17.07-20.21-23.44-25.06-24.77-16.84
Gain (Loss) on Sale of Investments
0.730.741.621.540.1-
Other Unusual Items
0.63----0.31
Pretax Income
-15.72-19.47-21.82-23.52-24.67-16.53
Earnings From Continuing Operations
-15.72-19.47-21.82-23.52-24.67-16.53
Net Income
-15.72-19.47-21.82-23.52-24.67-16.53
Net Income to Common
-15.72-19.47-21.82-23.52-24.67-16.53
Net Income Growth
------
Shares Outstanding (Basic)
110000
Shares Outstanding (Diluted)
110000
Shares Change
14.60%20.20%39.42%29.87%9.12%572.11%
EPS (Basic)
-24.90-33.06-44.53-66.91-91.15-66.65
EPS (Diluted)
-24.90-33.06-44.53-66.91-91.15-66.65
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.62-15.57-16.88-18.89-15.73-12.22
Free Cash Flow Per Share
-23.15-26.44-34.44-53.75-58.14-49.26
EBITDA
-17.26-20.76-23.64-25.02-24.72-16.74
D&A For EBITDA
0.120.140.190.220.210.15
EBIT
-17.38-20.9-23.83-25.24-24.93-16.89
SEC Filings: 10-K · 10-Q